Biotech New Lows: Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX), Curis (NASDAQ:CRIS), Targacept , Inc. (NASDAQ:TRGT), SIGA Technologies (NASDAQ:SIGA) , TrovaGene Inc (NASDAQ:TROV)

On MAY 8, 2014 Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX)), a biopharmaceutical company focused on developing breakthrough treatments for human disease, today updated its drug development progress and reported financial results for the three months ended March 31, 2014.Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) weekly performance is 0.74%. On last trading day company shares ended up $1.36. Analysts mean target price for the company is $2.83. Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) distance from 50-day simple moving average (SMA50) is -16.77%.

On MAY 12, 2014 Curis, Inc. (NASDAQ:CRIS) is one of the most shorted stocks of the Russell 3000, based on 8.86 “days to cover” versus the median component at 4.95. There are a number of ways to look at short data, but one metric that we find particularly useful is the “days to cover” because it considers both the total shares short and the average daily volume of shares typically traded. Curis, Inc. (NASDAQ:CRIS) shares fell -3.54% in last trading session and ended the day on $1.91. CRIS Gross Margin is 98.70% and its return on assets is -17.00%. Curis, Inc. (NASDAQ:CRIS) quarterly performance is -36.75%.

Targacept , Inc. (NASDAQ:TRGT) has recently released its first quarter 2014 results. The company reported a total net loss of $15.0 million in this period compared to loss of $8.1 million in the prior year quarter.Targacept , Inc. (NASDAQ:TRGT) shares moved up 3.20% in last trading session and was closed at $3.87, while trading in range of $3.63 – $3.91. Targacept , Inc. (NASDAQ:TRGT) year to date (YTD) performance is -6.75%.

On MAY 1, 2014 SIGA Technologies, Inc. (NASDAQ:SIGA) reported its financial results for the quarter ended March 31, 2014. Revenue for the three months ended March 31, 2014 was $549,000, compared to $1.3 million in the first quarter of 2013, and the operating loss for the quarter was $5.6 million, compared to $5.8 million for the comparable quarter last year. SIGA Technologies, Inc. (NASDAQ:SIGA) ended the last trading day at $2.66. Company weekly volatility is calculated as 4.22% and price to cash ratio as 1.33. SIGA Technologies, Inc. (NASDAQ:SIGA) showed a negative weekly performance of -3.27%

TrovaGene Inc (NASDAQ:TROV) issued a press release announcing its financial results for the three months ended March 31, 2014. The information disclosed under this Item 2.02, including Exhibit 99.1 hereto, is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended. TrovaGene Inc (NASDAQ:TROV) weekly performance is -14.82%. On last trading day company shares ended up $4.08. Analysts mean target price for the company is $10.00. TrovaGene Inc (NASDAQ:TROV) distance from 50-day simple moving average (SMA50) is -25.37%.

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *